In vivo efficacy of PA21A050. Four indicated doses of PA21A050 were administered orally to groups of 3 NOD/scid/IL2R null mice each engrafted with human erythrocytes and infected with P. falciparum. The compound was administered starting at day 3 post infection for 4 consecutive days. Parasitemia was assessed each day from day 3 post infection up to 7 days (A). Concentrations of PA21A050 were measured by LC/MS at 0.25, 0.5, 1, 2, 4, 7, 10, and 23 h after the first dose (B). Comparison of morphology of parasitized human RBC in vehicle treated (C) and PA21A050 treated (D) mice revealed parasites with only highly pyknotic staining in treated mice.
In vivo efficacy of PA21A102. Four indicated doses of PA21A102 were administered orally to groups of 3 NOD/scid/IL2R null mice each engrafted with human erythrocytes and infected with P. falciparum. The compound was administered starting at day 3 post infection for 4 consecutive days. Parasitemia was assessed each day from day 3 post infection up to 7 days (A). Concentrations of PA21A102 were measured by LC/MS in each mouse at 0.25, 0.5, 1, 2, 4, 7, 10, and 23 h after the first dose (B). The estimated drug exposure necessary to inhibit P. falciparum parasitemia at day 7 post infection by 90% (AUC ED90 ) was 0.24 µg.h.ml -1 .day -1 (C). Comparison of morphology of parasitized human RBC in vehicle treated (D) and PA21A102 treated (E) mice revealed parasites with only highly pyknotic staining in treated mice. . Growth inhibition curves for three independent lines derived from Dd2 parasites exposed to compound C2-1. Each of the resistant line had similar EC 50 for compound C2-1 with some variation the curve slope. (B). Compound C2-1 resistant parasite line does not have cross-resistance to the spiroindolone NITD246. P. falciparum line Dd2 and its compound C2-1-resistant derivative, Dd2-R21, were used to test efficacy of the spiroindolone compound NITD246 in a growth inhibition assay. T392A allele. Experimental details and the location of the specific primers used are presented in the SI Materials and methods. Tg, DNA from transgenic parasites; Wt, DNA from wild type parasite used for PCR amplifications. (C) Strategy to produce transgenic lines expressing wildtype or V178I mutant allele of PfATP4. Dd2attB line bearing attB sequence in the cg6 locus were co-transfected with pLN-ATP4-HA and pINT plasmids. The integrase encoded by pINT facilitates recombination between the attP sequence on pLN-ATP4-HA plasmid and the attB sequence, thereby generating the sequence shown at the bottom. Primer pairs P2 and P4 were used to confirm integration. We also used the same pLN-ATP4-HA plasmids (bearing the wildtype or mutant allele) to transfect Dd2::PfCDPK5 T392A parasites generated above. Here the plasmid was maintained with blasticidin drug pressure. 
where R is the emission fluorescence ratio (from excitation at 340 nm/380 nm) for the unknown [Na + ] i , R min is the emission ratio at 0 mM Na + , R max is the emission ratio at saturating Na + (achieved at 130 mM Na + ), K d is the Na + dissociation constant of the dye, S f is the fluorescence emission at 380 nm excitation for the free indicator (0 mM Na + ) and S b is the fluorescence emission at 380 nm excitation for the Na + -bound indicator (130 mM Na + ). Under physiological conditions K d for SBFI is 17 -19 mM (4, 5). The calculation of the individual terms comprising K d S f /S b is difficult, due to uncertainties in calculating a true value of S b (2, 6). Therefore an alternative calibration approach, established by Diarra and colleagues (2001) In experiments in which the pH i changed over the period in which [Na + ] i was measured, a correction factor was applied to distinguish between the changes in signal due to the pHdependence of SBFI and the changes in the SBFI signal due to [Na + ] i changes The correction required was calculated as described previously (1, 2) is the pH i (measured using the pH-sensitive dye BCECF-AM) and σ is an experimentally-determined constant. The "7.3" included in Equation 4 is the resting pH i of the mature P. falciparum trophozoite (7-11). σ was determined experimentally by performing the standard calibration at varying pH o values (see Supplementary Figure 1C in (1)). An average σ of 1.73 ± 0.12 (n = 6) was determined and used throughout this study. (C) Representative calibration trace for BCECF-loaded parasites in which pH i was equilibrated to pH o , over a range of pH o values, using nigericin (30 μM). The traces, showing the fluorescence ratio (excitation at 495 nm/440 nm, with emission recorded at 520 nm) increasing with pH i , are representative of those obtained in three independent experiments for this study and are similar to those described previously (7, 12, 13) . A separate calibration was performed for each experiment. (D) Representative calibration curve, derived from the traces shown in C. For all such calibration curves the fluorescence ratio at each pH i was averaged over approximately 120 s and plotted as a function of pH i (equilibrated with pH o ). The data were fitted by a straight line (typically R 2 > 0.98) which was then used to convert the measured fluorescence ratio to pH i . (E) Calibration trace for Fura-2-loaded parasites, representative of those obtained in three independent experiments for this study. At the end of each Fura-2 trace recorded in this study CaCl 2 and the Ca 2+ -ionophore ionomycin (final concentrations 3 mM and 30 μM, respectively) were added to the cell suspension and incubated at 37 ˚C for 30 min. This allows an estimate of the maximum fluorescence ratio value (R max , as in Equation 1). To determine R min , 12.8 mM of the Ca 2+ -chelator Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) and 91 mM Tris(hydroxymethyl)aminomethane was added, and R min (at both wavelengths) was recorded once fluorescence had stabilised. Fluorescence ratios were converted to [Ca 2+ ] i using the Grynkiewicz equation:
where R is the fluorescence ratio (excitation at 340 nm/380 nm, with emission recorded at 515 nm) for the unknown [Ca 2+ ] i , R min is the fluorescence ratio at 0 mM Ca 2+ (in the presence of EGTA), R max is the fluorescence ratio at saturating Ca 2+ (achieved at 3 mM Ca 2+ ), K d is the Ca 2+ dissociation constant for the dye, S f is the fluorescence emission at 380 nm excitation for the free indicator (0 mM Ca 2+ ) and S b is the fluorescence emission at 380 nm excitation for the Ca 2+ -bound indicator (3 mM Ca 2+ ). Under physiological conditions K d for Fura-2 is approximately 140 nM (Molecular Probes Product information; revised Feb 2, 2011). This approach for calibration of Fura-2 loaded parasites (as used previously (14)) is different from that used for SBFI-/BCECF-loaded parasites (i.e. generation of a multi-point calibration curve as in B/D) and was taken due to the difficulties in preparing solutions of accurately-defined [Ca 2+ ]. Activity of 4 antimalarial drugs and PA21A092 were assessed in nine different strains of P. falciparum. Resistance profile of strains used is: 3D7 -sensitive; HB3 -Pyrimethamine resistant; Dd2 -Chloroquine, Mefloquine, Pyrimethamine and Sulfadoxine resistant; Tm90C2A -Chloroquine and Pyrimethamine resistant; Tm90C2B -Chloroquine, Atovaquone, Pyrimethamine and Cycloguanil resistant; T9/94 -Chloroquine resistant; V1/S -Chloroquine and Pyrimethamine resistant; TC08 -Pyrimethamine resistant; FCR3 -Chloroquine, Atovaquone and Cycloguanil resistant. PA21A092 was orally administered to four groups of 3 mice each with the indicated dose. Blood samples of 25 µl were collected for determination of PA21A092 levels by LC/MS. * t=10 h for the doses of 0.4, 2.0 and 10 mg/kg; t=23 h for the dose of 50 mg/kg.
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